The clinical data management systems (CDMS) market is expected to progress steadily by 2030 as a result of rising number of clinical trials across the globe. In addition, the growing healthcare sector, along with rapid developments in the pharmaceutical industry, is likely to augment market growth over the forecast period.

Clinical data management systems or CDMS refers to data management solutions that store data gathered from clinical trials and scientific studies. Rising prevalence of clinical data management solutions among CROs and medical device companies to keep track of clinical data has been impelling product adoption.

The COVID-19 outbreak created unprecedented demand for testing across the globe, prompting clinical laboratories to scale up their operations to tackle various pandemic-induced challenges. Thus, increased need for clinical laboratories to minimize turnaround times and initiate timely treatment of COVID-19 positive patients to curb the spread of the pandemic has been favorable for clinical data management systems (CDMS) market expansion.

Moreover, the pharmaceutical industry also registered huge production of medicines that required efficient data management for rigorous process assurance, which boosted the clinical data management systems industry growth positively in recent years. Furthermore, key industry participants have been engaging in tactical growth decisions, such as partnerships, collaborations, and product development to expand their business presence in the clinical data management systems (CDMS) market.

For instance, in February 2021, for instance, eClinical Solutions, a clinical trials data solutions company, launched the elluminate Clinical Trial Management System (CTMS). The innovation encourages digitalization and decreases the review cycle time for clinical data as well as serves as an efficient solution for informed decision making. Later, in November 2021, the firm integrated its Risk-based Quality Management (RBQM) technology in the elluminate Clinical Data Cloud to help clinical teams transform several data streams into actionable insights and analytics.

The clinical data management systems (CDMS) market has been bifurcated on the basis of end-use, delivery mode, and region.

In terms of delivery mode, the industry has been divided into web-hosted (on-demand) solutions, licensed enterprise (on-premise) solutions, and cloud-based (SAAS) solutions. The web-hosted solutions segment was valued at above $679.6 million in 2021 and is slated to grow significantly over the analysis timespan.

With regards to end-use, the clinical data management systems market has been categorized into medical device companies, contract research organizations (CRO), pharma/biotech companies, and others. The contract research organizations segment is anticipated to register a valuation of around $2.6 billion by the end of 2030.

In the regional frame of reference, the Latin America CDMS industry accounted for approximately 7.5% market share in 2021. Meanwhile, the Middle East & Africa clinical data management systems (CDMS) market is projected to exhibit substantial growth at a CAGR of over 11.8% through the review period.